Email Updates

Search form

You are here

19 SEPTEMBER 2014 VOLUME 15 ISSUE 38

Media Coverage

  • Like others whose medical careers began before the creation of global health as an identifiable discipline, Judy Wasserheit has moved away from a background dominated by biomedical models, and gone on to embrace a variety of social and environmental factors from inequality to climate change. At the start of this month, she took over as Chair of the University of Washington's Department of Global Heath in Seattle, USA.
    September 18, 2014
    Lancet
  • ...I recently decided to be public about my use of PrEP in order to raise awareness about this relatively new tool for preventing HIV. It's important to encourage people at risk for HIV to talk to their medical providers about all the tools and methods available for preventing infection, including PrEP, and to choose the methods that are best for them. As an elected official, disclosing this personal health decision was a hard but necessary choice.
    September 17, 2014
    Huffington Post
  • A San Francisco supervisor is asking the city to provide a HIV prevention drug to all residents free of charge. If successful, San Francisco would be the first city in the world to distribute...Truvada as PrEP, or “pre-exposure prophylaxis.” David Campos, who plans to introduce the resolution at the Board of Supervisor meeting Tuesday night, cites statistics that estimate fewer than 1,000 San Franciscans have access to the prevention drug.
     
    September 16, 2014
    CBS
  • While the Department of Health gears up for the next phase of its vaccine campaign to prevent cervical cancer in young girls, older South African women are left with an ineffective screening programme to prevent the killer cancer.
    September 16, 2014
    Health-e
  • Medicins Sans Frontières (MSF) has introduced a “night clinic” to provide HIV testing. “...To put more people on treatment has to start with detecting those who do not know they are HIV positive,” Kim Stambuli, MSF, said. “But for this to be possible, it is necessary to reach the high hanging fruits; those who do not have access to HIV testing. “This is what MSF does with its night clinic in Zimbabwe....”
     
    September 16, 2014
    Daily News
  • Kenyan taxpayers will have to part with approximately Sh4 billion annually to provide sex workers with a daily HIV and Aids prevention pill. According to an expert budgetary report prepared for the Government, for every one male or female prostitute, the country will spend about Sh48,667 annually to protect this high risk group from getting infected. Comparatively, the national free maternity care, one of Jubilee's flagship programmes, has been allocated Sh4 billion in the current financial year.
    September 16, 2014
    Standard
  • As clinical studies on Pre-Exposure Prophylaxis enter their stages, discussion of the controversial HIV prevention method has begun in Australia's gay community. Benjamin Riley navigates the emotionally-charged debate over whether this radical new took for fighting HIV means the end of the world as we know it.
     
        
    September 15, 2014
    Star Observer
  • A recent ad campaign from the AIDS Healthcare Foundation has kicked off a new round of controversy about HIV pre-exposure prophylaxis (PrEP) and how to interpret apparently conflicting numbers from prevention studies.
    September 15, 2014
    HIV & Hepatitis
  • A pretty young woman was sitting in the examining room with her right forefinger stretched out on the table for inspection. I had never seen her before, but at first glance, she looked fine, and so did the finger. An hour later — no exaggeration — it had become clear that the finger would recover, but the patient was an insoluble mess....She had been volunteering at a drop-in center for the homeless....

    September 15, 2014
    New York Times
  • Misuse and failure of birth control are major contributors to the millions of unplanned pregnancies in the United States....The longer any method of contraception is used, the greater the probability of unplanned pregnancy—the same way any small risk, taken repeatedly, grows in likelihood. This is true for all contraception methods. These charts show probabilities of pregnancy while using each method....
    September 13, 2014
    New York Times
  • A clinical trial known as Evidence for Contraceptive Options and HIV Outcomes (ECHO)—originally designed to answer important questions about possible connections between risk of HIV infection and the use of non-barrier hormonal contraceptives—now hangs in the balance because of a funding shortfall. For women in countries and communities with limited contraceptive choices and high rates of HIV, particularly in sub-Saharan Africa, this is an unacceptable development.
    September 12, 2014
    RH Reality Check
  • The challenges women have faced in protecting themselves from HIV...impelled the search for methods of prevention they could control. But do the new products, promising in the laboratory, and then in some trial settings, meet those challenges? Where are the opportunities to take a pivotal moment in biomedical answers to HIV, and ensure their promise is realized? The new supplement on Women and ARV-based prevention from the Journal of the International AIDS Society sets out to answer such questions.
     
    September 10, 2014
    Science Speaks
  • 2014 has not been the best year for good news on progress toward a cure for HIV....At ICAAC 2014, a major gathering of infectious disease experts, we heard speeches and spoke with leading HIV researchers about their evolving feelings regarding our fraught pathway toward a cure and the efforts currently underway to get us there.
     
    September 10, 2014
    TheBodyPRO.com

Published Research

  • Knowledge of HIV-positive status is associated with more frequent condom use in Mozambique. However, most HIV-infected persons are unaware of their serostatus, with men and persons in the poorest wealth quintile being more likely to be unaware. These findings support calls for expanded HIV testing, especially among groups less likely to be aware of their HIV status and key populations at higher risk for infection.

    September 15, 2015
    PLoS ONE
  • The global pregnancy rate decreased only slightly from 2008 to 2012, after declining substantially between 1995 and 2008. Approximately 40% of pregnancies worldwide, or 85 million pregnancies, were unintended in 2012, of which 50% ended in abortion, 13% in miscarriage, and 38% in an unplanned birth. 56% of all pregnancies were in Asia, 25% in Africa, 8% in Latin America and Caribbean, 7% in Europe, 3% in North America, and less than 1% in Oceania.
    September 18, 2014
    Studies in Family Planning
  • We aimed to determine whether interactive text messages improved clinic attendance and early infant HIV testing in the Nyanza region of Kenya. Text messaging significantly improved maternal postpartum visit attendance, but overall return rates for these visits remained low. In contrast, high rates of early infant HIV testing were achieved in both arms, with significantly higher testing rates in the SMS compared to the control infants.
    September 18, 2014
    AIDS
  • We investigated late HIV diagnosis and late initiation of combination antiretroviral therapy (cART) by educational level, a proxy of socioeconomic position....Among 15 ,414 individuals, median CD4+ cell count at cART initiation was lower with poorer educational level. Socioeconomic inequalities in delayed HIV diagnosis and initiation of cART are present in European countries with universal healthcare systems and individuals with lower educational level do not equally benefit from timely cART initiation.
     
    September 18, 2014
    AIDS
  • Enteropathogenic E. coli (EPEC) and Cryptosporidium infections were more common in HIV-infected and HIV-exposed children, respectively. This could explain the increased mortality attributed to these pathogens in other studies. Interventions targeting EPEC and Cryptosporidium may reduce morbidity and mortality in high HIV-prevalence settings.
    September 18, 2014
    AIDS
  • An Africa-specific, multi-site antiretroviral drug safety registry for pregnant women is feasible. Different prevalence for preterm delivery, delivery mode, and birth defect types between women on preconception ART in South Africa and Zambia highlight the potential impact of health systems on pregnancy outcomes. As countries establish ART drug safety registries, documenting health facility limitations may be as essential as the specific ART details.
     
    September 18, 2014
    AIDS
  • Point-of-care CD4 (POC-CD4) testing at the time of HIV diagnosis could improve survival and be cost-effective compared to laboratory-based CD4 testing (LAB-CD4) in Mozambique, if it improves linkage to care. POC-CD4 could have the greatest impact on mortality in settings where resources for HIV testing and linkage are most limited.

     

    September 18, 2014
    PLoS Med
  • Access to female-controlled contraceptive methods must be improved in order to help women and girls to counteract any risks to their reproductive health caused by intimate partner violence and reproductive coercion,* according to US experts writing in this week's PLOS Medicine, DOI: 10.1371/journal.pmed.1001723.
    September 16, 2014
    Science Daily
  • If you're not making regular trips to the vet for your kitty these days, you may not know that cats can get AIDS too.
    September 16, 2014
    Science Daily
  • We respond to infections in two fundamental ways. One...is "resistance," where the body attacks the invading pathogen and reduces its numbers. Another...is "tolerance," where the body tries to minimise the damage done by the pathogen. Now an elegant study using data from a large Swiss cohort of HIV-infected individuals gives us a tantalising glimpse into why some people cope with HIV better than others.
     
    September 16, 2014
    Science Daily
  • A vaginal ring that dispenses tenofovir protected all 6 macaque monkeys exposed to an HIV-like virus, while a heat-sensitive vaginal gel containing tenofovir nanoparticles prevented infection of mice, researchers reported at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy last week in Washington, DC. [References: Smith J, et al. Abstract H-998; Destache C, et al., Abstract H-997.]
     
    September 16, 2014
    HIV & Hepatitis
  • A large body of scientific evidence indicates that policies based solely on law enforcement without taking into account public health and human rights considerations increase the health risks of people who inject drugs (PWIDs) and their communities.... This commentary focuses primarily on drug policies and policing practices that increase PWIDs’ risk of acquiring HIV and viral hepatitis, and avenues for intervention.
    September 16, 2014
    Intl J Drug Policy
  • This is a crucial time for global health. Negotiations for the post-2015 development agenda are moving towards conclusion, and political priorities and machinations have resulted in many contentious debates, with inclusion of sexual and reproductive health and human rights within the Sustainable Development Goals (SDGs) the most controversial. It is impossible to read Lawrence Gostin's Global Health Law without this scenario in mind.
    September 13, 2014
    Lancet
  • Data from two large community surveys of African people living in England suggest that the proportion of people recently tested for HIV has increased over the last five years. There are also improvements in knowledge about HIV testing and treatment, suggesting that activities of health services and health promotion organisations may be bearing fruit. The findings come from the African Health and Sex Survey report published this week.
    September 8, 2014
    aidsmap
  • In their overview of the recent FLAMINGO study, Anton Pozniak and Jose Arribas conclude that we might be entering the integrase inhibitor era in HIV treatment, but ask whether innovative medicines like dolutegravir will be affordable. The question is particularly relevant in developing countries, including those most affected by the epidemic.
     
    September 6, 2014
    Lancet

Announcements

  • amfAR and the Center for LGBT Health Research at the University of Pittsburgh announce continuation of the amfAR HIV Scholars Program for junior investigators from low- and middle-income countries interested in conducting HIV research among gay men, other men who have sex with men, and/or transgender individuals (referred to here collectively as “GMT”). 
    CALL FOR APPLICATIONS deadline: 10 Oct 2014
    September 18, 2014
  • Nominations are being accepted until October 15 for this award, which recognizes early-career scientists who demonstrate both  excellence in their research careers and promoting meaningful dialogue between science and society. Award recipient will win $5,000, a commemorative plaque, and complimentary registration and travel to the 2015 AAAS Annual Meeting in San Jose, CA, USA. 
    September 17, 2014